Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul;24(3):295-302.
doi: 10.4103/0970-1591.42608.

Strategies for prostate cancer prevention: Review of the literature

H Krishna Moorthy, P Venugopal

Strategies for prostate cancer prevention: Review of the literature

H Krishna Moorthy et al. Indian J Urol. 2008 Jul.

Abstract

The goal of primary chemoprevention is to decrease the incidence of a given cancer, simultaneously reducing treatment-related adverse events, cost of treatment of the disease and mortality. Prostate cancer is an attractive and appropriate target for primary prevention because of its high incidence and prevalence, increased disease-related mortality, long latency and molecular pathogenesis and epidemiological data indicating that modifiable environmental factors may decrease risk. Various agents have been suggested to prevent prostate cancer and many clinical trials are currently on. Ultimately the adoption of a preventive strategy hinges on its potential benefits weighed against the potential risks of the specific agents used. This article is aimed to examine the experimental and epidemiological data spanning a period of 1998 to 2007, demonstrating the chemopreventive activity, safety and toxicity of various nutritional elements and other agents that can help prevent prostate cancer and/or slow disease progression.

Keywords: Chemoprevention; prostate cancer.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Similar articles

See all similar articles

Cited by

References

    1. Ross RK, Bernstein L, Lobo RA, Shimizu H, Stanczyk F, Pike M, et al. 5 Alpha reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet. 1992;339:887–9. - PubMed
    1. Pienta KJ, Esper PS. Risk factors for prostate cancer. Ann Intern Med. 1993;118:793–803. - PubMed
    1. Brawley OW. The potential for prostate cancer chemoprevention. Rev Urol. 2002;4:S11–7. - PMC - PubMed
    1. Kelloff GJ, Lieberman R, Steele VE, Boone CW, Lubet RA, Kopelovich L, et al. Chemoprevention of prostate cancer-concepts and strategies. Eur Urol. 1999;35:342–50. - PubMed
    1. Fisher B, Costantino JP, Wickerman DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer-report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst. 1998;90:1371–88. - PubMed